Ironwood Wins FDA Approval for Pediatric LINZESS
BOSTON — May 27, 2026 Ironwood Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved an...
Prescription, Generic, and Over-The-Counter: Drugs & Products.
Vanda Gains Japan Orphan Status for Imsidolimab
WASHINGTON, May 27, 2026 Vanda Pharmaceuticals Inc. has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has...
Nuvalent Expands Leadership in Precision Lung Cancer
CAMBRIDGE, Mass., May 27, 2026 Nuvalent, Inc., a clinical-stage biopharmaceutical company focused on developing precisely targeted cancer therapies, has...
Dizal Advances ZEGFROVY for EGFR Lung Cancer
SHANGHAI, China, May 27, 2026 Dizal, a biopharmaceutical company focused on developing targeted oncology therapies, has announced that China’s...
Hansa Biopharma Reports Positive Idefirix Results
LUND, Sweden, May 27, 2026 Hansa Biopharma AB has announced positive topline results from its European Post Authorization Efficacy...
Cosmos Health Targets $200M Revenue Growth by 2029
CHICAGO, United States, May 26, 2026 Cosmos Health Inc., a diversified and vertically integrated global healthcare company, has released...
Merz and Kvvit Partner to Expand INBRIJA Access
FRANKFURT, Germany and GANZHOU, China, May 26, 2026 Merz Therapeutics GmbH and Jiangxi Kvvit Pharmaceutical Co. Ltd. have announced...
Agios Secures EU Approval for PYRUKYND in Thalassemia
Cambridge, Massachusetts, USA, May 22, 2026 Agios Pharmaceuticals has announced that the European Commission (EC) has granted marketing authorization...
Persistence Market Research Predicts CGRP Inhibitors Market to Reach $12.5B
London, United Kingdom, May 25, 2026 The global market for CGRP inhibitors, one of the fastest-growing classes of migraine...
Pierre Fabre Gains CHMP Support for BRAFTOVI®
Castres, France, May 22, 2026 Pierre Fabre Laboratories has announced that the Committee for Medicinal Products for Human Use...